Fund Holdings — Commodore Capital LP

Total Portfolio Value:
$1.29B
Total Bought:
$226.46M
Total Sold:
$565.85M
Net Transaction:
-$339.39M
Notable People:
Michael Jonathan Kramarz, Robert Egen Turrell Atkinson, Commodore Capital Gp Llc
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Relay Therapeutics, Inc.(RLAY)12,000,00012,000,0000$224.52M$216.60M16.78%-$7.92M
Enliven Therapeutics Inc3,275,0003,275,0000$166.21M$150.13M11.63%-$16.08M
Alkermes plcSHS(ALKS)3,000,0002,875,360-124,640$157.19M$116.51M9.03%-$40.68M
Alto Neuroscience, Inc.(ANRO)2,723,1962,723,1960$71.87M$69.52M5.39%-$2.34M
Spyre Therapeutics, Inc.(SYRE)846,786700,000-146,786$75.18M$62.32M4.83%-$12.86M
Amylyx Pharmaceuticals, Inc.(AMLX)5,650,0002,000,000-3,650,000$101.47M$58.20M4.51%-$43.27M
LB Pharmaceuticals Inc(LBRX)1,500,0001,282,273-217,727$48.68M$49.21M3.81%+$531.1K
Damora Therapeutics Inc01,939,000+1,939,000$0$41.26M3.20%+$41.26M
Cogent Biosciences, Inc.(COGT)3,050,0001,265,000-1,785,000$118.03M$40.51M3.14%-$77.53M
Tyra Biosciences, Inc.(TYRA)1,875,0001,725,000-150,000$59.89M$37.73M2.92%-$22.16M
Celldex Therapeutics, Inc.(CLDX)1,350,0001,000,000-350,000$50.23M$32.41M2.51%-$17.82M
Pharvaris N V
COM
1,425,000925,000-500,000$49.28M$29.34M2.27%-$19.94M
Surrozen, Inc.(SRZN)0885,000+885,000$0$28.48M2.21%+$28.48M
Korsana Biosciences Inc0877,022+877,022$0$28.06M2.17%+$28.06M
Sagimet Biosciences Inc.COM SER A(SGMT)02,757,742+2,757,742$0$27.25M2.11%+$27.25M
Definium Therapeutics, Inc.(DFTX)2,000,000700,000-1,300,000$94.08M$26.64M2.06%-$67.44M
Adarx Pharmaceuticals Inc01,260,577+1,260,577$0$25.14M1.95%+$25.14M
Editas Medicine, Inc.(EDIT)8,889,0008,889,0000$28.80M$22.84M1.77%-$5.96M
Entera Bio Ltd.SHS(ENTX)07,352,941+7,352,941$0$21.40M1.66%+$21.40M
Attovia Therapeutics Inc01,160,000+1,160,000$0$19.88M1.54%+$19.88M
Agenus Inc.(AGEN)01,985,387+1,985,387$0$19.71M1.53%+$19.71M
Kymera Therapeutics, Inc.(KYMR)250,000175,000-75,000$28.67M$19.56M1.52%-$9.10M
InflaRx N.V.(IFRX)7,300,0009,268,220+1,968,220$16.35M$16.68M1.29%+$330.8K
Avalo Therapeutics, Inc.(AVTX)1,018,3191,018,3190$18.82M$15.61M1.21%-$3.21M
An2 Therapeutics Inc2,933,6802,933,6800$14.20M$15.61M1.21%+$1.41M
Century Therapeutics, Inc.(IPSC)8,695,6528,695,6520$21.30M$14.87M1.15%-$6.43M
Zura Bio LimitedCL A(ZURA)3,250,0003,250,0000$19.18M$13.52M1.05%-$5.66M
Inhibikase Therapeutics, Inc.(IKT)5,397,4885,397,4880$10.96M$11.09M0.86%+$134.9K
Assembly Biosciences Inc1,415,000461,922-953,078$38.88M$10.85M0.84%-$28.03M
PepGen Inc.(PEPG)4,475,0004,475,0000$8.05M$10.83M0.84%+$2.77M
SAB Biotherapeutics, Inc.(SABS)2,870,0002,870,0000$11.19M$9.10M0.70%-$2.10M
Relmada Therapeutics, Inc.(RLMD)1,425,0002,350,000+925,000$9.86M$8.86M0.69%-$1.00M
Research Alliance Corp IvCL A0500,000+500,000$0$5.79M0.45%+$5.79M
Helix Acquisition Corp. IIICL A(HLXC)500,000500,0000$5.32M$5.31M0.41%-$10.0K
Jatt Iii Acquisition Corp0400,000+400,000$0$4.41M0.34%+$4.41M
Tcgx Acquisition CorpCL A0300,000+300,000$0$3.75M0.29%+$3.75M
LeonaBio, Inc.(LONA)464,398464,3980$4.27M$1.66M0.13%-$2.61M
Damora Therapeutics, Inc.(DMRA)1,939,0000-1,939,000$50.43M$0—-$50.43M
EyePoint, Inc.(EYPT)4,600,0000-4,600,000$65.78M$0—-$65.78M
Nuvalent Inc100,0000-100,000$12.35M$0—-$12.35M
Perspective Therapeutics, Inc.(CATX)6,336,7820-6,336,782$21.61M$0—-$21.61M
Research Alliance Corp IiiCL A500,0000-500,000$5.35M$0—-$5.35M
Tango Therapeutics, Inc.(TNGX)2,250,0000-2,250,000$70.33M$0—-$70.33M
Vistagen Therapeutics, Inc.(VTGN)2,788,6200-2,788,620$630.2K$0—-$630.2K
Page 1 of 1
Commodore Capital LP — 13F Holdings — Q3 2026 | TickerTrail